Biomedical Research and Therapy

Scope & Guideline

Exploring the forefront of biomedical science and therapy.

Introduction

Welcome to your portal for understanding Biomedical Research and Therapy, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2198-4093
PublisherBIOMEDPRESS
Support Open AccessNo
Country-
TypeJournal
Convergefrom 2020 to 2024 (coverage discontinued in Scopus)
AbbreviationBIOMED RES THER / Biomed. Res. Ther.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBIOMEDPRESS, HO CHI MINH 00000, VIETNAM

Aims and Scopes

The journal 'Biomedical Research and Therapy' focuses on advancing knowledge in the biomedical sciences through interdisciplinary research, emphasizing the application of therapeutic strategies in clinical settings. Its core areas include innovative therapeutic approaches, clinical case studies, and the exploration of biological mechanisms underlying diseases.
  1. Stem Cell Research and Regenerative Medicine:
    The journal frequently publishes studies on the isolation, application, and therapeutic potential of stem cells, particularly mesenchymal stem cells, in various medical conditions, highlighting innovative techniques for stem cell therapy.
  2. Cancer Biology and Treatment:
    There is a strong emphasis on research related to cancer, including novel therapeutic strategies, biomarker identification, and case studies that explore the complexity of cancer treatment and management.
  3. Immunology and Infectious Diseases:
    Research in this journal often addresses the immune response to infections, vaccine development, and the role of immunotherapy in combating diseases, reflecting a growing interest in understanding host-pathogen interactions.
  4. Genetics and Molecular Biology:
    The journal explores the genetic basis of diseases, including polymorphism studies and molecular mechanisms, providing insights into potential genetic therapies and personalized medicine.
  5. Nutritional and Metabolic Health:
    The journal also investigates the links between nutrition, metabolism, and health outcomes, with studies focusing on dietary patterns, metabolic disorders, and their implications for disease prevention and management.
  6. Clinical Case Reports and Observational Studies:
    A significant portion of the journal's content is dedicated to clinical case reports and observational studies, which provide valuable insights into real-world patient management and treatment outcomes.
Recent publications in 'Biomedical Research and Therapy' reveal several emerging themes that reflect the evolving landscape of biomedical research, indicating areas of increasing interest and relevance.
  1. Immunotherapy and Cancer Treatment:
    There is a growing trend towards research on immunotherapy, including checkpoint inhibitors and novel vaccine designs, which represent cutting-edge approaches in the fight against cancer and infectious diseases.
  2. Microbiome Research:
    Studies exploring the role of the gut microbiome in health and disease, particularly its influence on cancer outcomes and metabolic health, are becoming increasingly prominent, highlighting the interconnectedness of gut health and systemic diseases.
  3. Personalized and Precision Medicine:
    Research focused on genetic predispositions, biomarkers, and personalized treatment strategies is on the rise, reflecting a broader trend towards tailoring medical treatments to individual patient profiles.
  4. Nanotechnology in Medicine:
    The use of nanotechnology for drug delivery and therapeutic applications is gaining traction, as evidenced by the increasing number of studies exploring its potential advantages in enhancing treatment efficacy and reducing side effects.
  5. Regenerative Medicine and Tissue Engineering:
    Emerging studies are increasingly focusing on the application of regenerative medicine techniques, including the use of biomaterials and stem cells for tissue repair and healing, indicating a shift towards innovative therapeutic approaches.

Declining or Waning

While 'Biomedical Research and Therapy' maintains a broad focus, some themes appear to be losing traction in recent publications, indicating potential shifts in research interests within the biomedical community.
  1. Traditional Pharmacology:
    Research focusing solely on traditional pharmacological approaches appears to be waning, with fewer studies dedicated to the development of conventional drugs without integrating modern techniques or genetic insights.
  2. Basic Science Without Clinical Relevance:
    There is a noticeable decline in studies that do not directly translate to clinical applications or therapeutic strategies, as the journal increasingly favors research with direct implications for patient care.
  3. Animal Studies Without Human Correlation:
    The frequency of purely animal model studies is decreasing, with a shift towards research that bridges findings from animal studies to human applications, reflecting the journal's focus on translational research.

Similar Journals

Cell and Bioscience

Unlocking the Secrets of Life at the Cellular Level
Publisher: BMCISSN: Frequency: 1 issue/year

Cell and Bioscience is a prestigious open-access journal published by BMC that has been at the forefront of biochemistry, genetics, and molecular biology since its inception in 2011. With an impressive impact factor, this journal has established itself as a vital resource for researchers and professionals in these rapidly advancing fields, reflecting its high ranking of #29 out of 221 in the Scopus classification and placing it in the 87th percentile. Based in the United Kingdom, Cell and Bioscience aims to foster innovation and dissemination of research findings addressing critical biological questions through rigorous peer-reviewed articles and inter-disciplinary approaches. The journal's open-access model ensures unrestricted access to transformative research, promoting collaboration and knowledge sharing among academics, students, and practitioners worldwide. With a commitment to maintaining excellence in the field, Cell and Bioscience provides an essential platform for those looking to contribute to the evolving landscape of biosciences.

BIOMEDICINE & PHARMACOTHERAPY

Empowering breakthroughs in biomedicine and therapy.
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 0753-3322Frequency: 12 issues/year

BIOMEDICINE & PHARMACOTHERAPY is a distinguished journal published by Elsevier France - Éditions Scientifiques Médicales Elsevier, specializing in the essential fields of medicine and pharmacology. Established in 1982 and covering literature up to 2024, this journal is notably recognized for its impact, holding a prestigious Q1 ranking in both Medicine (Miscellaneous) and Pharmacology, as well as a commendable position within the top 10% of its category based on Scopus rankings. Researchers and practitioners will find it serves as a vital resource for the latest advancements, innovations, and critical reviews in the life sciences and therapeutic practices. The journal emphasizes rigorous peer review and high-quality publications, aimed at facilitating knowledge dissemination in biomedicine and pharmacotherapy. Its commitment to excellence makes it an indispensable platform for contributors and readers alike who are engaged in improving health outcomes through pharmaceutical research and medical advances.

Biomedical Reports

Advancing knowledge in the heart of biomedical sciences.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9434Frequency: 6 issues/year

Biomedical Reports, published by SPANDIDOS PUBL LTD in Greece, is a distinguished open-access journal that focuses on the dynamic fields of biochemistry, genetics, molecular biology, medicine, pharmacology, and neuroscience. Established in 2014, the journal has rapidly gained recognition, securing Q2 and Q3 rankings in several categories for 2023, including a notable ranking of #125/636 in General Medicine, placing it in the 80th percentile amongst its peers. The journal continually aims to disseminate innovative research findings that advance the understanding of complex biomedical issues, making it an invaluable resource for researchers, professionals, and students alike. Its multidisciplinary approach not only reflects the interconnectivity of modern biomedical sciences but also promotes collaborative discourse among diverse fields, ensuring ongoing relevance and impact within the scientific community.

BIOMEDICAL RESEARCH-TOKYO

Connecting Global Researchers in Biomedical Sciences
Publisher: BIOMEDICAL RESEARCH PRESS LTDISSN: 0388-6107Frequency: 6 issues/year

BIOMEDICAL RESEARCH-TOKYO is an esteemed interdisciplinary journal published by BIOMEDICAL RESEARCH PRESS LTD, dedicated to disseminating pioneering research and advancements in the fields of biochemistry, genetics, and medicine. Since its inception in 1980, the journal has established itself as a reputable source of knowledge, contributing significantly to the global scientific community with its strong emphasis on innovative findings and methodologies. With a consistent presence in the Q3 quartile for both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023, it continues to attract a diverse range of research articles. While the journal does not operate as an open access platform, it remains an essential resource for researchers, professionals, and students seeking to further their understanding of biomedical sciences. Located in Sapporo, Japan, this journal fosters collaboration and knowledge sharing among the international biomedical research community, engaging readers through its compelling studies that span from 1980 to 2024.

Asian Biomedicine

Connecting Researchers to Transform Healthcare
Publisher: WALTER DE GRUYTER GMBHISSN: 1905-7415Frequency: 6 issues/year

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

CARDIOVASCULAR RESEARCH

Exploring the complexities of cardiovascular health.
Publisher: OXFORD UNIV PRESSISSN: 0008-6363Frequency: 18 issues/year

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.

Advanced Biomedical Research

Connecting Minds, Shaping the Future of Medicine
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2277-9175Frequency:

Advanced Biomedical Research, published by Wolters Kluwer Medknow Publications, is a prominent open access journal dedicated to advancing the field of biomedical research since its inception in 2012. With an ISSN of 2277-9175, this journal serves as a vital platform for researchers, professionals, and students to disseminate high-quality research findings and innovative ideas in a variety of topics within biochemistry, genetics, and molecular biology. Recognized within the Q3 category of the 2023 journal quartile rankings, it ranks 365th among general medicine journals and 187th in the general fields of biochemistry and genetics, underscoring its commitment to fostering scientific dialogue and collaboration. With its open access model, Advanced Biomedical Research ensures that research is readily accessible to a global audience, thereby enhancing the visibility and impact of scholarly work. As the journal continues to evolve through its converged editorial focus from 2019 to 2024, it aims to play a critical role in shaping the future of biomedical sciences in India and beyond.

POSTEPY BIOLOGII KOMORKI

Elevating Understanding in Cellular and Anatomical Research
Publisher: POLSKIE TOWARZYSTWO ANATOMICZNEISSN: 0324-833XFrequency: 4 issues/year

POSTĘPY BIOLOGII KOMÓRKI is a pivotal journal in the field of cell biology, published by the renowned Polskie Towarzystwo Anatomiczne. Since its inception, this journal has been dedicated to advancing scientific knowledge through the dissemination of high-quality research articles, reviews, and original studies focused on cellular structure and function. Although POSTĘPY BIOLOGII KOMÓRKI does not currently operate as an open-access journal, it remains a significant resource for researchers and professionals alike, contributing to critical discussions and findings in the biological sciences. The journal has undergone coverage discontinuation in Scopus, yet it continues to serve as an essential platform in Poland for scholarly exchange in cellular and anatomical research. Situated at the Centrum Medyczne Kształcenia Podyplomowego in Warsaw, it aims to bridge gaps in understanding and nurture academic growth among students and professionals in the biological sciences.

JOURNAL OF BIOMEDICAL SCIENCE

Empowering research through open access in biomedicine.
Publisher: BMCISSN: 1021-7770Frequency: 1 issue/year

JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.

Molecular Medicine Reports

Pioneering Insights into Genetics and Oncology
Publisher: SPANDIDOS PUBL LTDISSN: 1791-2997Frequency: 12 issues/year

Molecular Medicine Reports, an esteemed academic journal published by Spandidos Publications Ltd, serves as a vital platform for the dissemination of cutting-edge research in the field of molecular medicine. Established in 2008, this journal has rapidly ascended in prominence, currently positioned within the Q2 and Q3 quartiles across various critical categories including Biochemistry, Cancer Research, and Genetics, reflecting its significant impact and scholarly contributions. With an impressive Scopus ranking in multiple disciplines, including an 87th place in Oncology, it is recognized for publishing rigorous, peer-reviewed articles that bridge the gap between laboratory research and clinical applications. The journal’s commitment to advancing knowledge in molecular medicine is evident through its focus on innovative therapeutic approaches, genetic research, and oncological studies, catering to a diverse readership of researchers, professionals, and students in the biomedical field. Though not an open-access publication, it provides invaluable insights and fosters collaboration in the scientific community from its base in Athens, Greece.